Blastocyst Mutation Rate
Blastocyst Mutation Rate - Related Videos
07:44
Measuring Microbial Mutation Rates with the Fluctuation Assay
0 Views •
Cited by 35 •
2019
Here, a protocol is presented to perform a fluctuation assay and estimate microbial mutation rate using phenotypic markers. This protocol will enable researchers to assay mutations in diverse microbes and environments, determining how genotype and ecological context affect spontaneous mutation rates.
00:36
Viral Mutations
0 Views •
2019
A mutation is a change in the sequence of bases of DNA or RNA in a genome. Some mutations occur during replication of the genome due to errors made by the polymerase enzymes that replicate DNA or RNA. Unlike DNA polymerase, RNA polymerase is prone to errors because it is not capable of “proofreading” its work. Viruses with RNA-based genomes, like HIV, therefore accrue mutations faster than viruses with DNA-based genomes. Because mutation and recombination provide the raw material for adaptive...
10:59
Human Blastocyst Biopsy and Vitrification
0 Views •
Cited by 36 •
2019
Blastocyst biopsy and vitrification are required to efficiently conduct preimplantation genetic testing. An approach entailing the sequential opening of the zona pellucida and retrieval of 7-8 trophectoderm cells in day 5-7 post-insemination limits both the number of manipulations required and the exposure of the embryo to sub-optimal environmental conditions.
02:27
Mutations
0 Views •
2020
Mutations are changes in the sequence of DNA. These changes can occur spontaneously during DNA replication or be induced by environmental factors. Mutations can be characterized in several ways: by whether and how they alter the amino acid sequence of the protein, by the scale of the DNA affected, and by whether they affect somatic or germline cells.Consequences of Point Mutations at the Molecular LevelMutations that affect a single nucleotide are called point mutations. When point mutations...
02:27
Mutations
0 Views •
2026
Mutations are changes in the sequence of DNA. These changes can occur spontaneously during DNA replication or be induced by environmental factors. Mutations can be characterized in several ways: by whether and how they alter the amino acid sequence of the protein, by the scale of the DNA affected, and by whether they affect somatic or germline cells.Consequences of Point Mutations at the Molecular LevelMutations that affect a single nucleotide are called point mutations. When point mutations...
FAQs
Early embryonic divisions can distribute newly arising genetic changes unevenly. If a replication error, repair failure, or cellular injury occurs after some cells have already formed, the resulting mutation may be inherited by only a subset of descendants. This creates mosaicism, in which genetically different cell populations coexist within the developing blastocyst.
Three processes are highlighted as important contributors: errors during DNA replication, imperfect repair of damaged DNA, and cellular damage as embryonic cells divide. Their effects may differ depending on when they occur during development. A change arising earlier can influence more descendant cells, whereas a later event may remain restricted to a smaller cell population.
Mosaicism means that an analysis of one group of embryonic cells may not represent every cell in the blastocyst. Some cells can carry a mutation while others do not, making the distribution of genetic changes biologically important. This pattern helps researchers examine how early mutations relate to development and chromosomal abnormalities without treating the embryo as genetically uniform.
Researchers can estimate mutation frequency through genomic analysis of an embryo or through single-cell genomic analysis. Examining individual cells is especially relevant when mutations may be mosaic, because it can reveal whether a change is widespread or limited to particular cells. These approaches support investigation of genetic changes during preimplantation development and their potential biological significance.
Measurement can help clarify how genetic changes arise as embryonic cells divide and how those changes relate to early human development. It also supports research on chromosomal abnormalities and inherited disease risk. By connecting genomic findings with the blastocyst stage, investigators can study the biological consequences of mutations before implantation occurs.
In medicine, these measurements may improve understanding of embryo viability and reproductive outcomes, while also clarifying the biological consequences of preimplantation genetic testing. The findings are primarily useful for research interpretation: they can show how genetic variation is distributed among embryonic cells and help frame investigations into disease risk and developmental potential.